Liver replacement therapy with extracorporeal blood purification techniques current knowledge and future directions
作者机构:Intensive Care UnitGeneral Hospital of LarissaLarissa 41221ThessalyGreece Department of Transfusion MedicineUniversity Hospital of LarissaLarissa 41110ThessalyGreece Department of CardiologyUniversity Hospital of LarissaLarissa 41110ThessalyGreece Intensive Care UnitAHEPA University HospitalThessaloniki 54636Greece 1^(st) Department of Obstetrics and GynecologyGeneral Hospital of Athens“ALEXANDRA”National and Kapodistrian University of AthensAthens 11528Greece Department of AnesthesiologyUniversity Hospital of LarissaLarissa 41110ThessalyGreece
出 版 物:《World Journal of Clinical Cases》 (世界临床病例杂志)
年 卷 期:2023年第11卷第17期
页 面:3932-3948页
核心收录:
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
主 题:Liver failure Transplantation Blood purification Liver replacement therapy Artificial extracorporeal systems Transplant-free survival
摘 要:Clinically,it is highly challenging to promote recovery in patients with acute liver failure(ALF)and acute-on-chronic liver failure(ACLF).Despite recent advances in understanding the underlying mechanisms of ALF and ACLF,standard medical therapy remains the primary therapeutic *** transplantation(LT)is considered the last option,and in several cases,it is the only intervention that can be ***,this intervention is limited by organ donation shortage or exclusion criteria such that not all patients in need can receive a *** option is to restore impaired liver function with artificial extracorporeal blood purification *** first such systems were developed at the end of the 20th century,providing solutions as bridging therapy,either for liver recovery or *** enhance the elimination of metabolites and substances that accumulate due to compromised liver *** addition,they aid in clearance of molecules released during acute liver decompensation,which can initiate an excessive inflammatory response in these patients causing hepatic encephalopathy,multiple-organ failure,and other complications of liver *** compared to renal replacement therapies,we have been unsuccessful in using artificial extracorporeal blood purification systems to completely replace liver function despite the outstanding technological evolution of these *** middle to high-molecular-weight and hydrophobic/protein-bound molecules remains extremely *** majority of the currently available systems include a combination of methods that cleanse different ranges and types of molecules and ***,conventional methods such as plasma exchange are being re-evaluated,and novel adsorption filters are increasingly being used for liver *** strategies are very promising for the treatment of liver ***,the best method,system,or device has not been developed yet,and its probability of